These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7904767)

  • 1. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
    Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
    Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-2 agonists, exposure to allergens and bronchial hyperreactivity in children with allergic asthma].
    Piacentini GL; Peroni DG; Vicentini L; Benedetti M; Spezia E; Martinati LC
    Pediatr Med Chir; 1995; 17(6):515-7. PubMed ID: 8668586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients.
    Cloosterman SG; Bijl-Hofland ID; van Herwaarden CL; Akkermans RP; van Den Elshout FJ; Folgering HT; van Schayck CP
    Chest; 2001 May; 119(5):1306-15. PubMed ID: 11348933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposure.
    Valletta EA; Comis A; Del Col G; Spezia E; Boner AL
    Allergy; 1995 Apr; 50(4):366-9. PubMed ID: 7573822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
    Woolcock A; Lundback B; Ringdal N; Jacques LA
    Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness.
    Peroni DG; Boner AL; Vallone G; Antolini I; Warner JO
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1442-6. PubMed ID: 8004296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma control during and after cessation of regular beta 2-agonist treatment.
    Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE
    Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children.
    Benckhuijsen J; van den Bos JW; van Velzen E; de Bruijn R; Aalbers R
    Pediatr Pulmonol; 1996 Sep; 22(3):147-53. PubMed ID: 8893252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of bronchial hyperresponsiveness in asthmatic children.
    Stojković-Andjelković A; Obradović S; Vuletić B; Radlović N
    Srp Arh Celok Lek; 2011; 139(5-6):316-21. PubMed ID: 21858969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
    Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
    Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of food allergens on airway responsiveness in schoolchildren with asthma: A DBPCFC study.
    Krogulska A; Dynowski J; Jędrzejczyk M; Sardecka I; Małachowska B; Wąsowska-Królikowska K
    Pediatr Pulmonol; 2016 Aug; 51(8):787-95. PubMed ID: 26731485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broxaterol: therapeutic trials and safety profile.
    Ziment I
    Respiration; 1989; 55 Suppl 2():28-40. PubMed ID: 2572038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchial reactivity in asthmatic children at high and low altitude. Effect of budesonide.
    Boner AL; Comis A; Schiassi M; Venge P; Piacentini GL
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1194-200. PubMed ID: 7697252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
    Wong CS; Wahedna I; Pavord ID; Tattersfield AE
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.